Mary E. Rinella

University of Chicago Pritzker School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Collaborators (2)

Aleksander Krag

Odense University Hospital

DENMARK

View details

Juan Vaz

Lund University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mary E. Rinella

Research Interests

Explore related searches

Contact this professor

Articles (11)

The People-First Liver Charter.

Phosphatidylethanol in steatotic liver disease

Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis.

Call to action-Pediatric MASLD requires immediate attention to curb health crisis.

Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States.

Determining Cirrhosis Status in Candidates for Resmetirom.

Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.

Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease.

An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice.

Emerging therapies and real-world application of metabolic dysfunction-associated steatotic liver disease treatment.

Metabolic dysfunction–associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease

Collaborators (2)

Aleksander Krag

Juan Vaz

Make your next move.